Published in Clin Infect Dis on July 25, 2012
Influenza vaccine effectiveness in the community and the household. Clin Infect Dis (2013) 3.40
Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis (2013) 3.00
School-located influenza vaccination decreases laboratory-confirmed influenza and improves school attendance. Clin Infect Dis (2014) 1.70
Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011. PLoS One (2013) 1.64
Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type. J Infect Dis (2014) 1.62
Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis (2014) 1.44
Evolution of the immune system in humans from infancy to old age. Proc Biol Sci (2015) 1.31
Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review. Expert Rev Vaccines (2014) 1.25
Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility. J Infect Dis (2014) 1.23
Annual public health and economic benefits of seasonal influenza vaccination: a European estimate. BMC Public Health (2014) 1.11
Influenza transmission in a cohort of households with children: 2010-2011. PLoS One (2013) 1.07
Influenza and other respiratory virus infections in outpatients with medically attended acute respiratory infection during the 2011-12 influenza season. Influenza Other Respir Viruses (2014) 1.07
Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. J Infect Dis (2016) 1.02
CD4 T cell help is limiting and selective during the primary B cell response to influenza virus infection. J Virol (2013) 1.02
Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine. Pediatrics (2016) 0.98
Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season. Clin Infect Dis (2013) 0.98
Factors associated with influenza vaccine receipt in community dwelling adults and their children. Vaccine (2014) 0.97
2012-2013 Seasonal influenza vaccine effectiveness against influenza hospitalizations: results from the global influenza hospital surveillance network. PLoS One (2014) 0.97
Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong. BMC Infect Dis (2014) 0.93
Influenza vaccination coverage and effectiveness in young children in Thailand, 2011-2013. Influenza Other Respir Viruses (2015) 0.91
Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong - A decision analysis. Hum Vaccin Immunother (2015) 0.89
The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings. Int J Epidemiol (2016) 0.88
Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14. Vaccine (2015) 0.88
Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults. Infect Chemother (2013) 0.87
Antiviral treatment among older adults hospitalized with influenza, 2006-2012. PLoS One (2015) 0.86
Influenza vaccine prevents medically attended influenza-associated acute respiratory illness in adults aged ≥50 years. J Infect Dis (2014) 0.86
Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination. JAMA (2015) 0.85
Comparison of the immunogenicity and safety of the conventional subunit, MF59-adjuvanted, and intradermal influenza vaccines in the elderly. Clin Vaccine Immunol (2014) 0.84
Effectiveness of the 2010 and 2011 Southern Hemisphere trivalent inactivated influenza vaccines against hospitalization with influenza-associated acute respiratory infection among Thai adults aged ≥ 50 years. Influenza Other Respir Viruses (2014) 0.84
Effectiveness of seasonal influenza vaccine against clinically diagnosed influenza over 2 consecutive seasons in children in Guangzhou, China: a matched case-control study. Hum Vaccin Immunother (2013) 0.84
Seasonal influenza vaccine effectiveness among children, 2010-2012. Influenza Other Respir Viruses (2013) 0.83
Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty. Vaccine (2013) 0.83
Elementary school-based influenza vaccination: evaluating impact on respiratory illness absenteeism and laboratory-confirmed influenza. PLoS One (2013) 0.83
Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United States. Vaccine (2015) 0.83
Vaccination of healthcare workers: A review. Hum Vaccin Immunother (2015) 0.83
Seasonal influenza vaccine effectiveness in children during 2010-2011 season: a case-cohort study. Hum Vaccin Immunother (2013) 0.82
Detection of influenza virus infection using two PCR methods. Adv Virol (2014) 0.82
Preclinical evaluation of Vaxfectin-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines. Hum Vaccin Immunother (2013) 0.81
Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated. J Infect Dis (2015) 0.81
Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany. BMC Infect Dis (2015) 0.80
Suboptimal effectiveness of the 2011-2012 seasonal influenza vaccine in adult Korean populations. PLoS One (2015) 0.80
Viral infections in outpatients with medically attended acute respiratory illness during the 2012-2013 influenza season. BMC Infect Dis (2015) 0.80
Seasonal incidence of medically attended respiratory syncytial virus infection in a community cohort of adults ≥50 years old. PLoS One (2014) 0.79
Incidence of Medically Attended Respiratory Syncytial Virus and Influenza Illnesses in Children 6-59 Months Old During Four Seasons. Open Forum Infect Dis (2016) 0.79
Declining influenza vaccination coverage among nurses, Hong Kong, 2006-2012. Emerg Infect Dis (2013) 0.79
Relative timing of influenza disease by age group. Vaccine (2014) 0.79
Influenza vaccine effectiveness assessment through sentinel virological data in three post-pandemic seasons. Hum Vaccin Immunother (2014) 0.79
Real-time real-world analysis of seasonal influenza vaccine effectiveness: method development and assessment of a population-based cohort in Stockholm County, Sweden, seasons 2011/12 to 2014/15. Euro Surveill (2016) 0.78
A computational method for identification of vaccine targets from protein regions of conserved human leukocyte antigen binding. BMC Med Genomics (2015) 0.78
Effectiveness of seasonal influenza vaccinations against laboratory-confirmed influenza-associated infections among Singapore military personnel in 2010-2013. Influenza Other Respir Viruses (2014) 0.78
Contribution of influenza viruses to medically attended acute respiratory illnesses in children in high-income countries: a meta-analysis. Influenza Other Respir Viruses (2016) 0.78
Costs and benefits of influenza vaccination: more evidence, same challenges. BMC Public Health (2014) 0.77
Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trial. Clin Vaccine Immunol (2013) 0.77
Predictors of Influenza Diagnosis Among Patients With Laboratory-Confirmed Influenza. J Infect Dis (2015) 0.77
Simulation study of the effect of influenza and influenza vaccination on risk of acquiring Guillain-Barré syndrome. Emerg Infect Dis (2015) 0.76
A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines. Immun Inflamm Dis (2014) 0.76
Influenza Vaccine Effectiveness in a Low-Income, Urban Community Cohort. Clin Infect Dis (2015) 0.75
Multi-scale modeling for the transmission of influenza and the evaluation of interventions toward it. Sci Rep (2015) 0.75
Geographical heterogeneity and influenza infection within households. BMC Infect Dis (2014) 0.75
M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice. Vaccine (2016) 0.75
Analyses of Merging Clinical and Viral Genetic Data for Influenza Surveillance. AMIA Annu Symp Proc (2015) 0.75
Trivalent influenza vaccine-induced antibody response to circulating influenza a (H3N2) viruses in 2010/11 and 2011/12 seasons. Hum Vaccin Immunother (2015) 0.75
Influenza evolution and H3N2 vaccine effectiveness, with application to the 2014/2015 season. Protein Eng Des Sel (2016) 0.75
Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses. Pediatr Infect Dis J (2016) 0.75
Hospitalizations and outpatient visits for rhinovirus-associated acute respiratory illness in adults. J Allergy Clin Immunol (2015) 0.75
Effectiveness of vaccination and wearing masks on seasonal influenza in Matsumoto City, Japan, in the 2014/2015 season: An observational study among all elementary schoolchildren. Prev Med Rep (2016) 0.75
Effect of Statin Use on Influenza Vaccine Effectiveness. J Infect Dis (2016) 0.75
Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains. J Infect Dis (2016) 0.75
Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain. PLoS One (2017) 0.75
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis (2011) 14.93
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep (2010) 10.59
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med (1998) 6.75
Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med (2007) 6.54
Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med (2006) 4.50
Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med (2011) 4.46
Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA (2010) 4.21
Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med (2009) 3.49
Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol (2007) 3.33
Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis (2009) 3.26
Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis (2009) 2.68
Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis (2009) 2.59
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep (2011) 2.24
Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adults. Clin Infect Dis (2010) 2.16
Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season. MMWR Morb Mortal Wkly Rep (2008) 2.01
Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. PLoS One (2011) 1.94
Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. Vaccine (2009) 1.71
Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons. BMC Infect Dis (2010) 1.53
Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example. BMC Infect Dis (2009) 1.47
Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older. Vaccine (2009) 1.19
Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71
Influenza-associated hospitalizations in the United States. JAMA (2004) 18.23
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep (2010) 10.59
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep (2008) 9.02
The burden of respiratory syncytial virus infection in young children. N Engl J Med (2009) 8.95
The underrecognized burden of influenza in young children. N Engl J Med (2006) 8.25
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA (2006) 8.06
Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis (2012) 8.02
Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med (2005) 6.83
Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. JAMA (2005) 5.84
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep (2009) 5.80
Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics (2004) 5.74
Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med (2003) 5.60
Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet (2007) 5.50
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep (2007) 5.32
Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2006) 5.19
Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study. Lancet (2002) 5.17
Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J Infect Dis (2004) 4.82
Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med (2007) 4.69
Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA (2009) 4.61
Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med (2006) 4.50
The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med (2003) 4.37
Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med (2007) 4.16
Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med (2005) 4.04
Real-time reverse transcription-PCR assay for comprehensive detection of human rhinoviruses. J Clin Microbiol (2007) 3.95
Evidence of a causal role of winter virus infection during infancy in early childhood asthma. Am J Respir Crit Care Med (2008) 3.84
Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis (2001) 3.73
Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial. Ann Intern Med (2006) 3.72
Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis (2006) 3.66
Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA (2011) 3.58
Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med (2009) 3.49
Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. Am J Epidemiol (2006) 3.48
Influenza vaccine effectiveness in the community and the household. Clin Infect Dis (2013) 3.40
Rhinovirus-associated hospitalizations in young children. J Infect Dis (2007) 3.35
Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis (2012) 3.35
Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol (2007) 3.33
Low sensitivity of rapid diagnostic test for influenza. Clin Infect Dis (2009) 3.31
Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis (2009) 3.26
Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children. J Infect Dis (2004) 3.25
Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. Antimicrob Agents Chemother (2005) 3.04
Quantum walks of correlated photons. Science (2010) 3.04
Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. J Infect Dis (2010) 3.02
Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis (2013) 3.00
The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis (2004) 2.96
Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA (2006) 2.93
Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans. Lancet Infect Dis (2008) 2.93
Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study. Ann Intern Med (2010) 2.90
Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2003) 2.86
The burden of influenza-associated critical illness hospitalizations. Crit Care Med (2014) 2.84
Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respir Viruses (2009) 2.82
Household responses to school closure resulting from outbreak of influenza B, North Carolina. Emerg Infect Dis (2008) 2.74
Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial. Ann Intern Med (2010) 2.73
Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. J Infect Dis (2005) 2.72
Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine (2013) 2.69
Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis (2007) 2.60
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat Med (2010) 2.59
Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol (2006) 2.56
A novel group of rhinoviruses is associated with asthma hospitalizations. J Allergy Clin Immunol (2008) 2.53
COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet (2002) 2.49
Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections. JAMA (2010) 2.48
Detection and control of influenza outbreaks in well-vaccinated nursing home populations. Clin Infect Dis (2004) 2.48
Density interactions among Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in the nasopharynx of young Peruvian children. Pediatr Infect Dis J (2013) 2.47
Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data. Pharmacoepidemiol Drug Saf (2008) 2.46
Accuracy and interpretation of rapid influenza tests in children. Pediatrics (2007) 2.43
Outbreak of variant influenza A(H3N2) virus in the United States. Clin Infect Dis (2013) 2.38
Seasonality, timing, and climate drivers of influenza activity worldwide. J Infect Dis (2012) 2.30
Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics (2008) 2.29
Human herpesvirus (HHV)-6 and HHV-7 infections in pregnant women. J Infect Dis (2007) 2.29
Increasing burden and risk factors for bronchiolitis-related medical visits in infants enrolled in a state health care insurance plan. Pediatrics (2008) 2.29
Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med (2014) 2.27
Influence of maternal asthma on the cause and severity of infant acute respiratory tract infections. J Allergy Clin Immunol (2012) 2.26
Influenza- and RSV-associated hospitalizations among adults. Vaccine (2006) 2.23
Monitoring influenza activity in the United States: a comparison of traditional surveillance systems with Google Flu Trends. PLoS One (2011) 2.21
Maternal asthma and maternal smoking are associated with increased risk of bronchiolitis during infancy. Pediatrics (2007) 2.20
Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. J Infect Dis (2011) 2.19
Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study. Ann Intern Med (2012) 2.18
Influenza burden for children with asthma. Pediatrics (2008) 2.10
Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am J Obstet Gynecol (2003) 2.09
Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. Clin Infect Dis (2010) 2.09
Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics (2004) 2.08